Tien Liang BioTech Co., Ltd. (4127) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tien Liang BioTech Co., Ltd. (4127:TWSE), powered by AI.

Current Price
$71.20
Sector
Healthcare
What is the Tien Liang BioTech Co., Ltd. stock price forecast?

Tien Liang BioTech Co., Ltd. is currently trading at $71.20. View real-time AI analysis on Alpha Lenz.

What is Tien Liang BioTech Co., Ltd. insider trading activity?

View the latest insider trading data for Tien Liang BioTech Co., Ltd. on Alpha Lenz.

What is Tien Liang BioTech Co., Ltd.'s P/E ratio?

View Tien Liang BioTech Co., Ltd.'s valuation metrics on Alpha Lenz.

Tien Liang BioTech Co., Ltd.

TWSE · 4127
NT$71.20+2.40(+3.49%)
Ask about Tien Liang BioTech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Tien Liang BioTech Co., Ltd.'s ROE is -2.2%. Explore profitability and growth together.

Ask for details

Company Overview

Tien Liang BioTech Co., Ltd. is a specialty and generic drug manufacturer headquartered in New Taipei City, Taiwan. Established in 1960, the company produces and markets an extensive range of pharmaceutical products, serving both domestic and international markets. Its portfolio includes traditional Chinese medicine formulations targeting conditions such as liver and kidney deficiencies, rheumatism, joint pain, and various common ailments such as coughs and colds. Tien Liang BioTech also offers western medicine products including ointments, tablets, capsules, pain relief gels, sprays, and patches. In addition to pharmaceuticals, the company manufactures health foods, personal care items, and specialty healthcare products designed for body relaxation and post-exercise comfort. With a focus on research and development, Tien Liang BioTech plays a vital role in advancing healthcare options within Taiwan and beyond, providing both consumer and wholesale solutions in the healthcare sector.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees88

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$511.79MRevenue
0.00Shares Out
88Employees

Margins

56.26%Gross
1.84%EBITDA
-3.15%Operating
-2.30%Pre-Tax
-2.00%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-1.07%Rev 3Yr
3.49%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.99%ROA
-2.15%ROE
-0.06%ROIC

Financial Health

NT$122.31MCash & Cash Equivalents
NT$586.88MNet Debt
149.61%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Tien Liang BioTech Co., Ltd. (ticker: 4127) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 88 employees.

The current price is 71.2 with a P/E ratio of -x and P/B of -x.

ROE is -2.15% and operating margin is -3.15%. Annual revenue is $512M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Tien Liang BioTech Co., Ltd. (4127) Stock Forecast 2026 $71.20 — Price, Financials & Analyst Targets | Alpha Lenz